Bempedoic Acid: New Evidence Transforming the LDL-C Treatment Landscape

What You Will Learn

  • Review the clinical trial data for bempedoic acid, emphasizing its safety, efficacy, and long-term cardiovascular outcomes. 
  • Explain the mechanism of action of bempedoic acid and its role in lipid-lowering therapy. 
  • Identify station-intolerant patients who may benefit from bempedoic acid and integrate this therapy into clinical practice. 
  • Develop treatment plans tailored to the needs of statin-intolerant patients, leveraging bempedoic acid as a key therapeutic option.

A Closer Look at LDL-C Management: The Bempedoic Acid Solution

This infographic explores the importance of LDL-C in ASCVD Prevention

 

We are grateful to these distinguished faculty who contributed to this collection:

Chairs

Erin D. Michos, MD, MHS, FACC

 

Faculty

Alison Bailey, MD, FACC
Leslie Cho, MD, FACC 
Stephen J. Nicholls, MBBS, PhD, FACC 
Joseph Saseen, PharmD, MNLA, CLS 
Semenawit Burka, MD 
Emily Littman, MD 

Educational Grant Support Provided By: Esperion

Page Launched: September 2023

Android App Download IOS App Download Powered By